-
Benign familial polycythaemia in a young male.
Hematology reports 20120102
-
Treatment of polycythemia vera with hydroxyurea and pipobroman: final results of a randomized trial initiated in 1980.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111010
-
Thrombocytosis: diagnostic evaluation, thrombotic risk stratification, and risk-based management strategies.
Thrombosis 20110101
-
The CYTO-PV: A Large-Scale Trial Testing the Intensity of CYTOreductive Therapy to Prevent Cardiovascular Events in Patients with Polycythemia Vera.
Thrombosis 20110101
-
Emerging treatments for essential thrombocythemia.
Journal of blood medicine 20110101
-
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Bioorganic & medicinal chemistry letters 20101101
-
Polycythemia vera.
Internal and emergency medicine 20101001
-
Inhibition of allogeneic inflammatory responses by the Ribonucleotide Reductase Inhibitors, Didox and Trimidox.
Journal of inflammation (London, England) 20100101
-
Essential thrombocythemia: past and present.
Internal and emergency medicine 20091001
-
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Journal of medicinal chemistry 20081113
-
[Confluent indurated facial nodules and pustules in a 55-year-old man].
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20080901
-
A case of bromoderma and bromism.
The British journal of dermatology 20080201
-
Pipobroman gets regulatory approval outside Germany.
Deutsches Arzteblatt international 20080101
-
Practical approach to treating essential thrombocythaemia: case studies.
European journal of haematology. Supplementum 20071001
-
A review of the therapeutic agents used in the management of polycythaemia vera.
Hematological oncology 20070601
-
The treatment of polycythaemia vera: an update in the JAK2 era.
Internal and emergency medicine 20070301
-
Essential thrombocythemia.
Orphanet journal of rare diseases 20070101
-
[Multiples squamous cell carcinomas during treatment with pipobroman].
Annales de dermatologie et de venereologie 20070101
-
Long-term incidence of hematological evolution in three French prospective studies of hydroxyurea and pipobroman in polycythemia vera and essential thrombocythemia.
Seminars in thrombosis and hemostasis 20060601
-
Del(5q) and MLL amplification in homogeneously staining region in acute myeloblastic leukemia: a recurrent cytogenetic association.
Annals of hematology 20060401
-
Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study.
Blood 20050401
-
Cytogenetic response to pipobroman in Philadelphia-positive chronic myeloid leukemia with thrombocythemic onset.
Annals of hematology 20050201
-
Cytoreductive therapy for patients with essential thrombocythemia at high risk of thromboembolic complications. The difficult choice of the optimal drug.
Haematologica 20041101
-
Long-term follow-up of young patients with essential thrombocythemia treated with pipobroman.
Annals of hematology 20040801
-
Long-term evaluation of 164 patients with essential thrombocythaemia treated with pipobroman: occurrence of leukaemic evolution.
British journal of haematology 20031101
-
Polycythemia vera.
Hematology/oncology clinics of North America 20031001
-
Pharmacotherapy of essential thrombocythaemia: economic considerations.
Expert opinion on pharmacotherapy 20030901
-
Treatment of polycythemia vera and essential thrombocythemia: the role of pipobroman.
Leukemia & lymphoma 20030901
-
Treatment indications and choice of a platelet-lowering agent in essential thrombocythemia.
Current hematology reports 20030501
-
Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia.
Haematologica 20030101
-
Transition of essential thrombocythemia to megakaryoblastic leukemia after long-term therapy with sequential busulfan, pipobroman and hydroxyurea.
Acta haematologica 20030101
-
Long-term outcomes of polycythemia vera patients treated with pipobroman as initial therapy.
The hematology journal : the official journal of the European Haematology Association 20030101
-
[Polycythemia vera].
La Revue du praticien 20021015
-
Acute myeloid leukemia (AML) having evolved from essential thrombocythemia (ET): distinctive chromosome abnormalities in patients treated with pipobroman or hydroxyurea.
Leukemia 20021001
-
What is the standard treatment in essential thrombocythemia.
International journal of hematology 20020801
-
Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis.
British journal of haematology 20020301
-
Bone marrow aplasia after pipobroman: an immune-mediated mechanism?
British journal of haematology 20011201
-
[Multiple skin and mouth squamous cell carcinomas related to long-term treatment with hydroxyurea].
Annales de dermatologie et de venereologie 20010901
-
[Hydroxyurea--is it a harmless drug in Vaquez disease?]].
Pathologie-biologie 20010301
-
Management of patients with essential thrombocythemia: current concepts and perspectives.
Pathologie-biologie 20010301
-
Current treatment practice for essential thrombocythaemia in adults.
Expert opinion on pharmacotherapy 20010301
-
[Synthesis and anti-tumor activities of 1,4-bis[3-(amino-dithiocarboxy)propionyl] piperazine derivatives].
Yao xue xue bao = Acta pharmaceutica Sinica 20010301
-
Aplastic anemia responsive to cyclosporine complicating the evolution of polycythemia vera.
Leukemia & lymphoma 19990501
